![]() |
Application of serum anti-Müllerian hormone levels in selecting patients with polycystic ovary syndrome for
Hyun Ha Seok, Haengseok Song, Sang Woo Lyu, You Shin Kim, Dong Ryul Lee, Woo Sik Lee, Tae Ki Yoon
Clin Exp Reprod Med. 2016;43(2):126-132. Published online 2016 Jun 23 DOI: https://doi.org/10.5653/cerm.2016.43.2.126
|
Citations to this article as recorded by
A fresh start for IVM: capacitating the oocyte for development using pre-IVM
Robert B Gilchrist, Tuong M Ho, Michel De Vos, Flor Sanchez, Sergio Romero, William L Ledger, Ellen Anckaert, Lan N Vuong, Johan Smitz
Human Reproduction Update.2024; 30(1): 3. CrossRef Clinical outcomes from ART in predicted hyperresponders: in vitro maturation of oocytes versus conventional ovarian stimulation for IVF/ICSI
L Mostinckx, E Goyens, S Mackens, C Roelens, L Boudry, V Uvin, I Segers, C Schoemans, P Drakopoulos, C Blockeel, M De Vos
Human Reproduction.2024; 39(3): 586. CrossRef Anti-Mullerian Hormone and Fertility Treatment Decisions in Polycystic Ovary Syndrome: A Literature Review
Duru Shah, Padma Rekha Jirge
Journal of Human Reproductive Sciences.2024; 17(1): 16. CrossRef Outcomes of subsequent IVF cycles among women with PCOS after the first unstimulated IVM treatment: a single-center matched retrospective case-control study
Ya-Lan Xu, Wei Guo, Yong-Xiu Hao, Shuo Yang, Rong Li, Xiao-Ying Zheng, Jie Qiao
The Journal of Maternal-Fetal & Neonatal Medicine.2024;[Epub] CrossRef Outcomes of clinical in vitro maturation programs for treating infertility in hyper responders: a systematic review
Lan N. Vuong, Toan D. Pham, Tuong M. Ho, Michel De Vos
Fertility and Sterility.2023; 119(4): 540. CrossRef Outcomes of the Next In Vitro Fertilization Cycle in Women with Polycystic Ovary Syndrome after a Failed In Vitro Maturation Attempt
Wei Guo, Yalan Xu, Tian Tian, Shuo Yang, Rong Li, Jie Qiao, Xiaoying Zheng
Journal of Clinical Medicine.2023; 12(17): 5761. CrossRef The value of ovarian hyperstimulation syndrome in predicting pregnancy outcome in women with polycystic ovarian syndrome and candidate for in vitro fertilization: A case-control study
Shamim Pilehvari, Nahid Radnia, Somayeh Ahmadiani, Elaheh Talebi-Ghane, Neda Alimohammadi, Zahra Mousaei Tokaldani
International Journal of Reproductive BioMedicine .2023; 21(11): 921. CrossRef Successful live birth after in vitro maturation treatment in a patient with autoimmune premature ovarian failure: a case report and review of the literature
Lucie Chansel-Debordeaux, Elisabeth Rault, Chloé Depuydt, Volcy Soula, Claude Hocké, Clément Jimenez, Hélène Creux, Aline Papaxanthos-Roche
Gynecological Endocrinology.2021; 37(12): 1138. CrossRef In vitro maturation
Melanie L. Walls, Roger J. Hart
Best Practice & Research Clinical Obstetrics & Gyn.2018; 53: 60. CrossRef Evaluating the effects of administration of 25-hydroxyvitamin D supplement on serum anti-mullerian hormone (AMH) levels in infertile women
Zahra Naderi, Maryam Kashanian, Leily Chenari, Narges Sheikhansari
Gynecological Endocrinology.2018; 34(5): 409. CrossRef The Place of In Vitro Maturation in PCO/PCOS
Shital Julania, Melanie L. Walls, Roger Hart
International Journal of Endocrinology.2018; 2018: 1. CrossRef Predictive factors for live birth after in vitro maturation of oocytes in women with polycystic ovary syndrome
Samer Tannus, Safak Hatirnaz, Justin Tan, Baris Ata, Seang-Lin Tan, Ebru Hatirnaz, Mine Kenat-Pektas, Michael-Haim Dahan
Archives of Gynecology and Obstetrics.2018; 297(1): 199. CrossRef Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome
V. N. A. Ho, T. D. Pham, A. H. Le, T. M. Ho, L. N. Vuong
Journal of Ovarian Research.2018;[Epub] CrossRef
|